Novavax’s quarterly loss shrinks as it ramps down spending on COVID vaccines

(Reuters) - Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 vaccines, its only ...

Technology & Startups

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

November 12, 2024

By Patrick Wingrove (Reuters) -Novavax (NVAX) cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ...